961 results match your criteria: "centre de recherche sur l'inflammation[Affiliation]"
J Anesth Analg Crit Care
January 2025
Département d'anesthésie Réanimationéanimation, DMU PARABOL, AP-HP, Hôpital Beaujon, Clichy, France.
Eur Respir J
January 2025
Assistance Publique Hôpitaux Paris (AP-HP), Hôpital Bichat, Département de Médecine Interne, Paris, France
Int J Obes (Lond)
December 2024
Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III-Paul Sabatier (UT3), Toulouse, France.
Background: Understanding how obesity impacts human mammary adipose tissue (MAT) biology is crucial for deciphering its role in mammary epithelium during both physiological and pathophysiological processes, including breast cancer. Hypertrophic mammary adipocytes and Crown-Like Structures are present in MAT of patients with obesity but whether these changes initiate a fibro-inflammatory response at the tissue level remains insufficiently explored.
Objective: We investigated the markers of adipose tissue dysfunction (immune cell infiltration, secretion pattern and fibrosis) in tumor-free MAT of patients with obesity versus patients who are lean.
Immun Ageing
December 2024
Université Paris Cité, INSERM, PARCC, Paris, France.
Background: Immune ageing complicates cancer treatment in older individuals. While immunotherapy targeting the PD-1/PD-L1 pathway can reinvigorate T cells, these cells tend to become senescent with age. This study investigates different CD8 T cell subsets usually associated with senescence, in cancer patients over 70 years old who are undergoing anti-PD-1/PD-L1 immunotherapy, and examines the relationship between these senescent cells and prior chemotherapy exposure.
View Article and Find Full Text PDFFree Radic Biol Med
December 2024
INSERM-U1149, CNRS-ERL8252, Université de Paris-Cité, Centre de Recherche sur l'Inflammation, Laboratoire d'Excellence Inflamex, DHU FIRE, Faculté de Médecine, Site Xavier Bichat, Paris, France. Electronic address:
Neutrophils are essential for host defense against infections, but they also play a key role in acute and chronic inflammation. The protein tyrosine phosphatase non-receptor type 22 (PTPN22) gene encodes the lymphoid-specific tyrosine phosphatase (Lyp) and a genetic single-nucleotide polymorphism of PTPN22 rs2476601 (R620W) has been associated with several human autoimmune diseases, including rheumatoid arthritis (RA). Here, we investigated the role of Lyp in TNFα-induced priming of neutrophil ROS production and in the development of arthritis using new selective Lyp inhibitors.
View Article and Find Full Text PDFLancet Reg Health Eur
February 2025
Department of General Paediatrics, Paediatric Internal Medicine, Rheumatology and Infectious Diseases, National Reference Centre for Rare Paediatric Inflammatory Rheumatisms and Systemic Autoimmune Diseases (RAISE), Robert-Debré University Hospital, Assistance Publique-Hôpitaux de Paris, F-75019, Paris, France.
Background: Scurvy, historically rare in-high income countries, has re-emerged as an indicator of socioeconomic and dietary disparities. Limited data exist on scurvy trends among European children, particularly following socioeconomic changes since the COVID-19 pandemic. This study analysed scurvy incidence trends among French children over a nine-year period, examining potential post-pandemic increases.
View Article and Find Full Text PDFAnaesth Crit Care Pain Med
December 2024
Assistance Publique - Hôpitaux de Paris (AP-HP), Groupe Hospitalier St Louis-Lariboisière, Department of Anesthesiology and Critical Care and Burn Unit, Paris, France; University Paris Cite; Institut National de la Santé et de la Recherche Médicale (INSERM), INSERM UMR-S 942 Mascot, Lariboisière Hospital, Paris, France; INI-CRCT Network, Nancy, France; FHU PROMICE, Paris, France.
Med Sci (Paris)
December 2024
Centre de recherche sur l'inflammation Inserm U1149, université Paris Cité faculté de médecine, site Bichat, Paris, France.
Eur Radiol
December 2024
Department of Radiology, Beaujon Hospital, AP-HP.Nord, Clichy, France.
Objectives: This study evaluates the prognostic value of tumor response on CT at 3 months, assessed by Response Evaluation Criteria in Solid Tumors (RECIST), modified RECIST (mRECIST), and Liver Imaging Reporting and Data System Treatment Response Algorithm (LR-TRA) in patients with hepatocellular carcinoma (HCC) treated with selective internal radiation therapy (SIRT).
Materials And Methods: A retrospective analysis was conducted on 102 HCC patients treated with SIRT between 2018 and 2020. RECIST, mRECIST, and LR-TRA were assessed at 3 months post-SIRT.
Eur J Neurol
January 2025
Department of Internal Medicine, Hospital Bichat-Claude Bernard, Assistance Publique Hôpitaux de Paris, Université Paris Cité, Paris, France.
Background: Susac syndrome (SuS) is a rare immune-mediated microangiopathy with potential disabling evolution. We aimed to analyze brain microstructural damage through diffusion tensor imaging (DTI) in SuS and determine its association with poor outcomes.
Method: CarESS study is a prospective multicenter national cohort study of patients with SuS.
J Rheumatol
December 2024
Karim Sacré, MD, PhD, Département de Médecine Interne, Hôpital Bichat, AP-HP, Université Paris Cité, Paris; INSERM UMR 1149, Centre de Recherche sur l'Inflammation, Laboratoire d'Excellence Inflamex, Paris, France.
Med Sci (Paris)
November 2024
Centre de recherche sur l'inflammation, Inserm U 1149, université Paris Cité, faculté de médecine Bichat, Paris, France.
Med Sci (Paris)
November 2024
Université Paris Cité, Centre de recherche sur l'inflammation, Inserm UMR1149, CNRS EMR8252, Laboratoire d'excellence Inflamex, Paris, France.
Med Sci (Paris)
November 2024
Université Paris-Cité, Inserm, Centre de recherche sur l'inflammation, UMR1149, Paris, France - APHP, Hôpital européen George Pompidou, Hôpital Corentin-Celton, Service de gériatrie, Institut CARPEM, Paris, France.
Med Sci (Paris)
November 2024
Centre de recherche sur l'inflammation, Inserm U1149, Université Paris Cité, faculté de médecine Bichat, Paris, France.
PLoS Comput Biol
December 2024
Unit of Translational Bioinformatics, Navarrabiomed-Fundación Miguel Servet, Universidad Publica de Navarra (UPNA), IdiSNA, Pamplona, Spain.
In the era of precision medicine, it is necessary to understand heterogeneity among patients with complex diseases to improve personalized prevention and management strategies. Here, we introduce ClustAll, a Bioconductor package designed for unsupervised patient stratification using clinical data. ClustAll is based on the previously validated methodology ClustAll, a clustering framework that effectively handles intricacies in clinical data, including mixed data types, missing values, and collinearity.
View Article and Find Full Text PDFNephrol Dial Transplant
December 2024
Department of Nephrology, APHP Hôpital Bichat, 46 Rue Henri Huchard, Paris, INSERM U1149 centre de recherche sur l'inflammation, Université Paris Cité.
Background And Hypothesis: Kidney involvement, along with cardiac disease, is the most frequent manifestation of systemic AL amyloidosis usually resulting in nephrotic-range proteinuria. Rarely, deposits predominantly or exclusively affect the intrarenal arterioles or arteries, these vascular-limited forms following a distinct clinical course, but very little is known about these forms. Our work plan at better characterizing renal vascular limited AL amyloidosis.
View Article and Find Full Text PDFJ Hepatol
November 2024
Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, Institut de Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). CIBEREHD (Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas). Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE-Liver). Departament de Medicina i Ciències de la Salut. Universitat de Barcelona. Electronic address:
Hellenic J Cardiol
November 2024
Department of Anaesthesiology and Surgical Intensive Care Unit, Groupe Hospitalier Bichat Claude Bernard, DMU PARABOL, Assistance Publique-Hôpitaux de Paris, Paris, France; Department of Anesthesiology, Hôpital Louis Mourier, DMU PARABOL, Assistance Publique-Hôpitaux de Paris, Paris, France; Université Paris Cité, Atherothrombotic Disease in Heart and Brain, INSERM UMR 1148, Paris F-75018, France.
Objectives: Uric acid (UA) concentration is associated with increased risk of atrial fibrillation, but few studies have investigated this association after cardiac surgery. This study investigated the statistical association between postoperative atrial fibrillation (POAF) and preoperative UA concentration according to the type of cardiac surgery.
Methods: Consecutive patients undergoing cardiac surgery at a tertiary center from January to May 2019 were eligible.
JHEP Rep
December 2024
Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, Institut de InvestigacionsBiomèdiques August Pi iSunyer (IDIBAPS), Departament de Medicina I Ciències de la Salut - University of Barcelona, Barcelona. CIBEREHD (Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas). Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN-Rare Liver), Spain.
Background & Aims: Patients with vascular liver diseases (VLD) are at higher risk of both severe courses of COVID-19 disease and thromboembolic events. The impact of SARS-CoV-2 vaccination in patients with VLD has not been described and represents the aim of our study.
Methods: International, multicenter, prospective observational study in patients with VLD analyzing the incidence of COVID-19 infection after vaccination, severity of side effects, occurrence of thromboembolic events and hepatic decompensation.
Ann Pathol
November 2024
Université Paris Cité, Paris, France; Département de pathologie, FHU MOSAIC, SIRIC InSitu, hôpital Beaujon, AP-HP. Nord, Clichy, France; Centre de recherche sur l'inflammation, Inserm, UMR 1149, Paris, France.
Rev Med Interne
November 2024
Département de médecine interne, université Paris Cité, Hospital Bichat-Claude Bernard, AP-HP, Paris, France; Inserm UMR1149, CNRS ERL8252, laboratoire d'excellence Inflamex, faculté de médecine site Bichat, centre de recherche sur l'inflammation, Paris, France.
Expert Opin Emerg Drugs
December 2024
Department of Liver Cancer and Innovative Therapy Unit, Assistance Publique-Hôpitaux de Paris, Hôpital Beaujon, Clichy, France.
Introduction: Hepatocellular carcinoma (HCC), the most common primary liver cancer, is a major cause of cancer-related morbidity and mortality. Limited treatment options for advanced stages highlight the need for effective therapies.
Areas Covered: This review explores immune checkpoint inhibitors (ICIs), specifically PD-1, PD-L1, and CTLA-4 inhibitors, as emerging treatments for advanced HCC.
Blood Cells Mol Dis
February 2025
Service d'hémato-oncologie pédiatrique, Hôpital l'Archet, Nice, France.
Congenital microcytic anemias are rare diseases associated with decreased hemoglobin synthesis and red blood cells of low corpuscular volume. DMT1/NRAMP2 is a highly conserved divalent cation transporter encoded by the SLC11A2 gene, expressed at the membrane of various cells. It ensures ferrous iron absorption from the apical membrane of enterocytes, iron recovery from urine by renal tubules, and acidified endosome uptake after transferrin internalization.
View Article and Find Full Text PDFLancet Gastroenterol Hepatol
December 2024
Université Paris-Cité, Inserm, Centre de recherche sur l'inflammation, UMR 1149, Paris, France; Faculté de médecine de Tours, et service d'hépato-gastroentérologie, CHRU de Tours, ERN RARE-LIVER, Tours, France.